Sacroiliitis Market Research Report, by Diagnosis (Imaging Tests and Anesthetic Injections), Treatment (Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation), End-User (Hospitals, Diagnostic Centers) – Global Forecast Till 2030

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Sacroiliitis Market, by Diagnosis,

6.1 Introduction

6.2 Imaging Tests

6.2.1 X-ray

6.2.2 MRI

6.2.3 CT scan

6.3 Anesthetic Injections

Chapter 7. Global Sacroiliitis Market, by Treatment

7.1 Introduction

7.2 Medications

7.2.1 Pain Relievers

7.2.1 Muscle Relaxants

7.2.3 TNF Inhibitors

7.3 Joint Injections

7.4 Radiofrequency Denervation

7.5 Electrical Stimulation

7.6 Joint Fusion

7.7 Facet Block

7.8 Chiropractic Manipulation

7.9 Physical Therapy

Chapter 9. Global Sacroiliitis Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.3 Pharmacies

9.4 Diagnostic Centers

Chapter 10. Global Sacroiliitis Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Medacta International

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 SI-BONE

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Globus Medical

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Zyga Technology

12.4.1 Company Overview

12.4.2 Product Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Nutech Medical

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 CoorsTek Medical LLC

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 ASPEN MEDICAL PRODUCTS

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Medtronic

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Sacroiliitis Market Industry Synopsis, 2020–2027

Table 2 Global Sacroiliitis Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Sacroiliitis Market, by Region, 2020–2027, (USD Million)

Table 4 Global Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 5 Global Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 6 Global Sacroiliitis Market, by End-User, 2020–2027, (USD Million

Table 7 North America: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 8 North America: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 9 North America: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 10 US: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 11 US: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 12 US: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 13 Canada: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 Canada: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 15 Canada: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 16 South America: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 17 South America: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 18 South America: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 19 Europe: Sacroiliitis Market, Diagnosis, 2020–2027, (USD Million)

Table 20 Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 21 Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 22 Western Europe: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 23 Western Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 24 Western Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 25 Eastern Europe: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Eastern Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 27 Eastern Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 28 Asia-Pacific: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 29 Asia-Pacific: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 30 Asia-Pacific: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 31 Middle East & Africa: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 32 Middle East & Africa: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 33 Middle East & Africa: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Sacroiliitis Market

Figure 3 Market Dynamics for Global Sacroiliitis Market

Figure 4 Global Sacroiliitis Market Share, by Diagnosis 2020

Figure 5 Global Sacroiliitis Market Share, by Treatment 2020

Figure 6 Global Sacroiliitis Market Share, by End-User, 2020

Figure 7 Global Sacroiliitis Market Share, by Region, 2020

Figure 8 North America Sacroiliitis Market Share, by Country, 2020

Figure 9 Europe Sacroiliitis Market Share, by Country, 2020

Figure 10 Asia-Pacific Sacroiliitis Market Share, by Country, 2020

Figure 11 Middle East & Africa Sacroiliitis Market Share, by Country, 2020

Figure 12 Global Sacroiliitis Market: Company Share Analysis, 2020 (%)

Figure 13 Medacta International: Key Financials

Figure 14 Medacta International: Segmental Revenue

Figure 15 Medacta International: Geographical Revenue

Figure 16 SI-BONE: Key Financials

Figure 17 SI-BONE: Segmental Revenue

Figure 18 SI-BONE: Geographical Revenue

Figure 19 Globus Medical: Key Financials

Figure 20 Globus Medical: Segmental Revenue

Figure 21 Globus Medical: Geographical Revenue

Figure 22 Zyga Technology: Key Financials

Figure 23 Zyga Technology: Segmental Revenue

Figure 24 Zyga Technology: Geographical Revenue

Figure 25 CoorsTek Medical LLC: Key Financials

Figure 26 CoorsTek Medical LLC: Segmental Revenue

Figure 27 CoorsTek Medical LLC: Geographical Revenue

Figure 28 Nutech Medical: Key Financials

Figure 29 Nutech Medical: Segmental Revenue

Figure 30 Nutech Medical: Geographical Revenue

Figure 31 ASPEN MEDICAL PRODUCTS: Key Financials

Figure 32 ASPEN MEDICAL PRODUCTS: Segmental Revenue

Figure 33 ASPEN MEDICAL PRODUCTS: Geographical Revenue

Figure 34 Medtronic: Key Financials

Figure 35 Medtronic: Segmental Revenue

Figure 36 Medtronic: Geographical Revenue